Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare
- 1 November 2012
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 17 (21-22), 1242-1248
- https://doi.org/10.1016/j.drudis.2012.04.004
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- What makes a good drug target?Drug Discovery Today, 2011
- Drug pipeline: Q311Nature Biotechnology, 2011
- New models emerge for commercializing university assetsNature Biotechnology, 2011
- Biotechs follow big pharma lead back into academiaNature Biotechnology, 2011
- Crowd sourcing in drug discoveryNature Reviews Drug Discovery, 2011
- Pfizer reaches out to academia—againNature Biotechnology, 2011
- Francis CollinsNature Reviews Drug Discovery, 2010
- Selective inhibition of BET bromodomainsNature, 2010
- How to improve R&D productivity: the pharmaceutical industry's grand challengeNature Reviews Drug Discovery, 2010
- Open access chemical and clinical probes to support drug discoveryNature Chemical Biology, 2009